A novel PRRS vaccine in a bacterial vector known to stimulate strong cell-mediated and humoral immunity
November 5, 2004
The results of this research project suggest that, despite several unique, advantageous properties, Brucella abortus RB51 is not very useful for developing effective recombinant PRRS vaccines.
